With a price-to-earnings (or "P/E") ratio of 53.2x Cosmo Pharmaceuticals N.V. ( VTX:COPN ) may be sending very bearish...
Medtronic's (MDT) GI Genius intelligent endoscopy module is the first FDA-cleared, AI-assisted colonoscopy tool to help physicians detect polyps that can lead to colorectal cancer.
Cosmo Pharmaceuticals N.V. / Key word(s): Annual Results23-March-2023 / 06:00 GMT/BSTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Ad hoc announcement pursuant to Art. 53 LR Dublin, Ireland – 23 March 2023: Cosmo Pharmaceuticals N.V. (SIX: COPN, XETRA: C43) (“Cosmo”) reports full-year 2022 financial results for the year ended 31 December 2022. Financial highlights In 2022, Cosmo has overtaken the €100 million annual